NASDAQ:YTEN Yield10 Bioscience (YTEN) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free YTEN Stock Alerts $2.10 +0.04 (+1.94%) (As of 05/29/2024 ET) Add Compare Share Share Today's Range$1.80▼$2.2550-Day Range$2.06▼$10.4352-Week Range$1.80▼$72.96Volume9,548 shsAverage Volume187,623 shsMarket Capitalization$1.34 millionP/E RatioN/ADividend YieldN/APrice Target$84.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Yield10 Bioscience alerts: Email Address Yield10 Bioscience MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside3,900.0% Upside$84.00 Price TargetShort InterestBearish8.73% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.26Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.68 out of 5 stars 3.2 Analyst's Opinion Consensus RatingYield10 Bioscience has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageYield10 Bioscience has received no research coverage in the past 90 days.Read more about Yield10 Bioscience's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted8.73% of the float of Yield10 Bioscience has been sold short.Short Interest Ratio / Days to CoverYield10 Bioscience has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Yield10 Bioscience has recently increased by 1,840.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldYield10 Bioscience does not currently pay a dividend.Dividend GrowthYield10 Bioscience does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YTEN. Previous Next 1.8 News and Social Media Coverage News SentimentYield10 Bioscience has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Yield10 Bioscience this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for YTEN on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Yield10 Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Yield10 Bioscience insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.10% of the stock of Yield10 Bioscience is held by insiders.Percentage Held by InstitutionsOnly 4.91% of the stock of Yield10 Bioscience is held by institutions.Read more about Yield10 Bioscience's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Yield10 Bioscience is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Yield10 Bioscience is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Yield10 Bioscience's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Yield10 Bioscience Stock (NASDAQ:YTEN)Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.Read More YTEN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YTEN Stock News HeadlinesMay 30 at 1:48 AM | americanbankingnews.comShort Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Expands By 1,840.0%May 23, 2024 | globenewswire.comYield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide LabelMay 22, 2024 | markets.businessinsider.comHold Rating on Yield10 Bioscience Amid Commercialization Challenges and Financial UncertaintiesMay 16, 2024 | investorplace.comYTEN Stock Earnings: Yield10 Bioscience Misses EPS, Misses Revenue for Q1 2024May 15, 2024 | marketwatch.comYield10 Bioscience Shares Plumb New Depths After Nasdaq DelistingMay 15, 2024 | globenewswire.comYield10 Bioscience Announces First Quarter 2024 Financial ResultsMay 15, 2024 | globenewswire.comYield10 Bioscience Announces Delisting from NasdaqMay 1, 2024 | markets.businessinsider.comYield10 Bioscience Sets 1-for-24 Reverse Stock SplitMay 1, 2024 | msn.comYield10 Bioscience to implement reverse stock splitMay 1, 2024 | globenewswire.comYield10 Bioscience Announces 1-for-24 Reverse Stock SplitApril 5, 2024 | finance.yahoo.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call TranscriptApril 3, 2024 | markets.businessinsider.comHold Recommendation on Yield10 Bioscience Amid Commercialization and Capital UncertaintiesApril 2, 2024 | finance.yahoo.comQ4 2023 Yield10 Bioscience Inc Earnings CallApril 1, 2024 | investorplace.comYTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023April 1, 2024 | benzinga.comYield10 Bioscience: Q4 Earnings InsightsApril 1, 2024 | globenewswire.comYield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | globenewswire.comYield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024March 26, 2024 | globenewswire.comYield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in CanadaMarch 23, 2024 | stockhouse.comUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 21, 2024 | markets.businessinsider.comDow Jumps 200 Points; US Weekly Jobless Claims FallMarch 21, 2024 | markets.businessinsider.comUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 21, 2024 | msn.comYield10 stock soars 120% on USDA okay for Camelina plantingMarch 21, 2024 | finance.yahoo.comUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesMarch 21, 2024 | investorplace.comWhy Is Yield10 (YTEN) Stock Up 117% Today?March 21, 2024 | globenewswire.comUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United StatesSee More Headlines Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today5/29/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural production - crops Sub-IndustryN/A Current SymbolNASDAQ:YTEN CUSIPN/A CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees29Year Founded1992Price Target and Rating Average Stock Price Target$84.00 High Stock Price Target$96.00 Low Stock Price Target$72.00 Potential Upside/Downside+3,900.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($36.4249) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,450,000.00 Net MarginsN/A Pretax Margin-4,381.67% Return on Equity-888.81% Return on Assets-262.09% Debt Debt-to-Equity RatioN/A Current Ratio0.34 Quick Ratio0.34 Sales & Book Value Annual Sales$60,000.00 Price / Sales22.40 Cash FlowN/A Price / Cash FlowN/A Book Value($5.16) per share Price / Book-0.41Miscellaneous Outstanding Shares640,000Free Float603,000Market Cap$1.34 million OptionableNot Optionable Beta1.68 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Oliver P. Peoples Ph.D. (Age 66)Co-Founder, President, CEO & Director Comp: $358.39kDr. Kristi D. Snell Ph.D. (Age 56)VP of Research & Chief Science Officer Comp: $287.14kMs. Lynne H. Brum (Age 60)VP of Planning & Corporate Communications and Secretary Comp: $287.14kMr. Charles B. Haaser (Age 68)VP of Finance, Chief Accounting Officer & Treasurer Comp: $236.41kKey CompetitorsArcadia BiosciencesNASDAQ:RKDAAfrican AgricultureNASDAQ:AAGREdible GardenNASDAQ:EDBLCortevaNYSE:CTVAFresh Del Monte ProduceNYSE:FDPView All CompetitorsInsidersJack W SchulerSold 1,500 sharesTotal: $7,560.00 ($5.04/share)Jack W SchulerSold 1,458 sharesTotal: $8,398.08 ($5.76/share)Jack W SchulerSold 1,580 sharesTotal: $11,376.00 ($7.20/share)Jack W SchulerSold 1,724 sharesTotal: $12,826.56 ($7.44/share)Jack W SchulerBought 31,875 shares on 8/15/2023Total: $497,250.00 ($15.60/share)View All Insider Transactions YTEN Stock Analysis - Frequently Asked Questions Should I buy or sell Yield10 Bioscience stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" YTEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in YTEN, but not buy additional shares or sell existing shares. View YTEN analyst ratings or view top-rated stocks. What is Yield10 Bioscience's stock price target for 2024? 3 Wall Street research analysts have issued twelve-month target prices for Yield10 Bioscience's stock. Their YTEN share price targets range from $72.00 to $96.00. On average, they predict the company's stock price to reach $84.00 in the next year. This suggests a possible upside of 3,900.0% from the stock's current price. View analysts price targets for YTEN or view top-rated stocks among Wall Street analysts. How have YTEN shares performed in 2024? Yield10 Bioscience's stock was trading at $5.7432 on January 1st, 2024. Since then, YTEN stock has decreased by 63.4% and is now trading at $2.10. View the best growth stocks for 2024 here. Are investors shorting Yield10 Bioscience? Yield10 Bioscience saw a increase in short interest in May. As of May 15th, there was short interest totaling 48,500 shares, an increase of 1,840.0% from the April 30th total of 2,500 shares. Based on an average daily volume of 169,400 shares, the days-to-cover ratio is currently 0.3 days. Currently, 8.7% of the company's stock are sold short. View Yield10 Bioscience's Short Interest. When is Yield10 Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our YTEN earnings forecast. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced its quarterly earnings results on Monday, April, 1st. The specialty chemicals company reported ($6.48) earnings per share for the quarter. When did Yield10 Bioscience's stock split? Shares of Yield10 Bioscience reverse split on Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD). How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:YTEN) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
